SCHEMBL1716976

SCHEMBL1716976

C[C@H](NC(C)(C)C)C(=O)O.C[C@H](NC(C)(C)C)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 5/20 0.44
SLC6A2 P23975 5/20 0.40
CHRNA1 P02708 4/20 0.40
CHRNG P07510 4/20 0.40
CHRNB1 P11230 4/20 0.40
CHRNB2 P17787 4/20 0.40
CHRNB4 P30926 4/20 0.40
CHRNA3 P32297 4/20 0.40
CHRNA4 P43681 4/20 0.40
CHRND Q07001 4/20 0.40
SLC6A4 P31645 4/20 0.39
ITGA5 P08648 1/20 0.39
CYP2C19 P33261 1/20 0.39
HRH1 P35367 1/20 0.39
CHRNA7 P36544 1/20 0.39
OPRK1 P41145 1/20 0.39
KCNH2 Q12809 1/20 0.39
TP53 P04637 1/20 0.38
ALDH1A1 P00352 2/20 0.38
BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289160 1.00 SLC6A3 (0.44) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL43590 1.00 SLC6A3 (0.44) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL43589 1.00 SLC6A3 (0.44) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
Hydrochloric Acid SCHEMBL29399049 0.97 SLC6A3 (0.42) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
Hydrochloric Acid SCHEMBL8190787 0.97 SLC6A3 (0.42) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
Hydrochloric Acid SCHEMBL8190786 0.97 SLC6A3 (0.42) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL2946675 0.85 SLC6A3 (0.36) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL2946672 0.85 SLC6A3 (0.36) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL24766215 0.84 MME (0.48) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL20677212 0.84 MME (0.48) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1713780-B1 NOVEL INHIBITORS OF GLUTAMINYL CYCLASE PROBIODRUG AG (DE) 2012-01-18 EP disclosed
EP-2338490-A2 Combinations Useful for the Treatment of Neuronal Disorders Probiodrug AG (DE) 2011-06-29 EP disclosed
US-7897633-B2 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism PROBIODRUG AG (DE) 2011-03-01 US disclosed